Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000621193 | SCV000736458 | likely benign | Cardiovascular phenotype | 2016-12-07 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000647276 | SCV000769065 | likely benign | Brugada syndrome 8 | 2024-01-18 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV001289447 | SCV001477266 | benign | not specified | 2020-08-20 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001529121 | SCV001889648 | likely benign | not provided | 2020-12-07 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV001529121 | SCV001742047 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV001289447 | SCV001918758 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001529121 | SCV001974670 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001529121 | SCV001979537 | likely benign | not provided | no assertion criteria provided | clinical testing |